Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, “window-of-opportunity” study

  1. Moreno, V.
  2. Sepúlveda, J.M.
  3. Reardon, D.A.
  4. Pérez-Núñez, Á.
  5. León, P.G.
  6. Hanna, B.
  7. Filvaroff, E.
  8. Aronchik, I.
  9. Chang, H.
  10. Amoroso, B.
  11. Zuraek, M.
  12. Sanchez-Perez, T.
  13. Mendez, C.
  14. Stephens, D.
  15. Nikolova, Z.
  16. Vogelbaum, M.A.
Revue:
Neuro-Oncology

ISSN: 1523-5866,  1522-8517

Année de publication: 2023

Volumen: 25

Número: 6

Pages: 1113-1122

Type: Article

DOI: 10.1093/NEUONC/NOAC263 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus